Ono Pharmaceutical Co (STU:ON4) FCF Margin % : 26.01% (As of Sep. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Ono Pharmaceutical Co FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Ono Pharmaceutical Co's Free Cash Flow for the three months ended in Sep. 2024 was €201 Mil. Ono Pharmaceutical Co's Revenue for the three months ended in Sep. 2024 was €773 Mil. Therefore, Ono Pharmaceutical Co's FCF Margin % for the quarter that ended in Sep. 2024 was 26.01%.

As of today, Ono Pharmaceutical Co's current FCF Yield % is 11.37%.

The historical rank and industry rank for Ono Pharmaceutical Co's FCF Margin % or its related term are showing as below:

STU:ON4' s FCF Margin % Range Over the Past 10 Years
Min: -5.39 Med: 15.54 Max: 32.45
Current: 19.23

During the past 13 years, the highest FCF Margin % of Ono Pharmaceutical Co was 32.45%. The lowest was -5.39%. And the median was 15.54%.

STU:ON4's FCF Margin % is ranked better than
89.24% of 994 companies
in the Drug Manufacturers industry
Industry Median: 0.9 vs STU:ON4: 19.23

Ono Pharmaceutical Co FCF Margin % Historical Data

The historical data trend for Ono Pharmaceutical Co's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ono Pharmaceutical Co FCF Margin % Chart

Ono Pharmaceutical Co Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

FCF Margin %

Get a 7-Day Free Trial

17.68

17.36

13.71

32.45

17.87

Ono Pharmaceutical Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
FCF Margin %	Get a 7-Day Free Trial															32.60	17.82	34.25	-1.67	26.01

Competitive Comparison of Ono Pharmaceutical Co's FCF Margin %

For the Drug Manufacturers - General subindustry, Ono Pharmaceutical Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ono Pharmaceutical Co's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ono Pharmaceutical Co's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Ono Pharmaceutical Co's FCF Margin % falls into.

Ono Pharmaceutical Co FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Ono Pharmaceutical Co's FCF Margin for the fiscal year that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (A: Mar. 2024 )	/	Revenue (A: Mar. 2024 )
	=	551.63	/	3086.788
	=	17.87 %

Ono Pharmaceutical Co's FCF Margin for the quarter that ended in Sep. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Sep. 2024 )	/	Revenue (Q: Sep. 2024 )
	=	201.082	/	773.118
	=	26.01 %

Ono Pharmaceutical Co FCF Margin % Related Terms

Thank you for viewing the detailed overview of Ono Pharmaceutical Co's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Ono Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ono Pharmaceutical Co Ltd (STU:ON4) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

OPHLY:USA OPHLF:USA 4528:Japan

Address

8-2, Kyutaromachi 1-chome, Chuo-ku, Osaka, JPN, 541-8564

Website

http://www.ono.co.jp

Ono Pharmaceutical Co Ltd is a drug manufacturer with a focus on drug discovery in areas of unmet medical needs. It maintains a world-wide business in specialty pharmaceuticals. The company breaks out its revenue of goods and products into eight segments. The vast majority of Ono's revenue is derived from its circulatory and respiratory drugs, followed by its metabolic drugs and vitamins. The company also reports revenue derived from royalties. The bulk of Ono's sales are generated in Japan, followed by the rest of Asia and Europe.

Ono Pharmaceutical Co Headlines

No Headlines